中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2015年
11期
8-10,15
,共4页
胡炜科%邵利江%虞松平%陈进
鬍煒科%邵利江%虞鬆平%陳進
호위과%소리강%우송평%진진
COPD急性加重期并2型呼吸衰竭%肺部感染评分%急性生理学与慢性健康状况评分
COPD急性加重期併2型呼吸衰竭%肺部感染評分%急性生理學與慢性健康狀況評分
COPD급성가중기병2형호흡쇠갈%폐부감염평분%급성생이학여만성건강상황평분
Acute exacerbation of COPD with type 2 respiratory failure%Pulmonary infection score%Acute physiology and chronic health evaluation
目的:探讨肺部感染评分和急性生理学与慢性健康状况评分对COPD急性加重期并2型呼吸衰竭患者预后评估的应用价值。方法选择2011年2月~2014年2月在我院住院治疗的COPD急性加重期并2型呼吸衰竭患者112例作为研究对象,比较生存组和死亡组患者两种评分方法的分值、两种评分方法不同分值患者实际病死率、两种评分方法对慢性阻塞性肺疾病急性加重期并呼吸衰竭预测死亡率的ROC曲线。结果两组患者PaO2、pH、PaCO2及HCO3-比较差异无统计学意义(t=1.742、1.647、1.791、1.082,P>0.05);但死亡组AG和潜在HCO3-指标水平高于生存组(t=10.865、5.993,P<0.05);生存组APACHEⅢ、CPIS评分均显著低于死亡组,差异均有统计学意义(t=6.254、4.397,P<0.05)。APACHⅢ评分≥25和CPIS评分≥6的患者病死率均显著高于低于此值的患者,差异有统计学意义(χ2=10.264、7.351,P<0.05)。 CPIS预测COPD急性加重期并2型呼吸衰竭死亡率,ROC曲线下面积为0.867,APACHEⅢ预测COPD急性加重期并2型呼吸衰竭死亡率,ROC曲线下面积为0.938。结论 CPIS和APACHEⅢ都对COPD急性加重期并2型呼吸衰竭患者预后评估有一定价值,但APACHEⅢ分辨度更佳,可为病情预测提供参考,值得临床应用推广。
目的:探討肺部感染評分和急性生理學與慢性健康狀況評分對COPD急性加重期併2型呼吸衰竭患者預後評估的應用價值。方法選擇2011年2月~2014年2月在我院住院治療的COPD急性加重期併2型呼吸衰竭患者112例作為研究對象,比較生存組和死亡組患者兩種評分方法的分值、兩種評分方法不同分值患者實際病死率、兩種評分方法對慢性阻塞性肺疾病急性加重期併呼吸衰竭預測死亡率的ROC麯線。結果兩組患者PaO2、pH、PaCO2及HCO3-比較差異無統計學意義(t=1.742、1.647、1.791、1.082,P>0.05);但死亡組AG和潛在HCO3-指標水平高于生存組(t=10.865、5.993,P<0.05);生存組APACHEⅢ、CPIS評分均顯著低于死亡組,差異均有統計學意義(t=6.254、4.397,P<0.05)。APACHⅢ評分≥25和CPIS評分≥6的患者病死率均顯著高于低于此值的患者,差異有統計學意義(χ2=10.264、7.351,P<0.05)。 CPIS預測COPD急性加重期併2型呼吸衰竭死亡率,ROC麯線下麵積為0.867,APACHEⅢ預測COPD急性加重期併2型呼吸衰竭死亡率,ROC麯線下麵積為0.938。結論 CPIS和APACHEⅢ都對COPD急性加重期併2型呼吸衰竭患者預後評估有一定價值,但APACHEⅢ分辨度更佳,可為病情預測提供參攷,值得臨床應用推廣。
목적:탐토폐부감염평분화급성생이학여만성건강상황평분대COPD급성가중기병2형호흡쇠갈환자예후평고적응용개치。방법선택2011년2월~2014년2월재아원주원치료적COPD급성가중기병2형호흡쇠갈환자112례작위연구대상,비교생존조화사망조환자량충평분방법적분치、량충평분방법불동분치환자실제병사솔、량충평분방법대만성조새성폐질병급성가중기병호흡쇠갈예측사망솔적ROC곡선。결과량조환자PaO2、pH、PaCO2급HCO3-비교차이무통계학의의(t=1.742、1.647、1.791、1.082,P>0.05);단사망조AG화잠재HCO3-지표수평고우생존조(t=10.865、5.993,P<0.05);생존조APACHEⅢ、CPIS평분균현저저우사망조,차이균유통계학의의(t=6.254、4.397,P<0.05)。APACHⅢ평분≥25화CPIS평분≥6적환자병사솔균현저고우저우차치적환자,차이유통계학의의(χ2=10.264、7.351,P<0.05)。 CPIS예측COPD급성가중기병2형호흡쇠갈사망솔,ROC곡선하면적위0.867,APACHEⅢ예측COPD급성가중기병2형호흡쇠갈사망솔,ROC곡선하면적위0.938。결론 CPIS화APACHEⅢ도대COPD급성가중기병2형호흡쇠갈환자예후평고유일정개치,단APACHEⅢ분변도경가,가위병정예측제공삼고,치득림상응용추엄。
Objective To investigate the prognosis value of pulmonary infection score and acute physiology and chronic health evaluation to acute exacerbation of COPD with type 2 respiratory failure. Methods 112 cases with acute exacer-bation of COPD with type 2 respiratory failure were selected as research subjects in our hospital from February 2011 to February 2014,scores of two scoring methods,actual mortality with different scores of two scoring methods,ROC curve predicted mortality of two scoring methods to chronic obstructive pulmonary disease with acute exacerbation of respira-tory failure of survival group and death group were compared. Results There were no significant differences between the two groups in PaO2、pH、PaCO2 and HCO3-(t=1.742, 1.647, 1.791, 1.082, P>0.05);but the levels of AG and poten-tial HCO3-in death group were higher than those in survival group(t=10.865, 5.993, P<0.05). APACHEⅢ,CPIS scores of survival group significantly were lower than the death group, the differences were statistically significant (t=6.254,4.397,P<0.05). Mortality of APACHⅢ score ≥25 and CPIS score ≥6 were significantly higher than patients with lower than that value, the differences were statistically significant(χ2=10.264,7.351,P<0.05). CPIS predict mortality acute exacerbation of COPD with type 2 respiratory failure, the area under the ROC curve was 0.867,APACHEⅢpredict mortality acute exacerbation of COPD with type 2 respiratory failure, the area under the ROC curve was 0.938. Conclusion CPIS and APACHEⅢ has certain prognostic value to acute exacerbation of COPD and type 2 respiratory failure,but APACHEⅢ resolution are better, it can provide a reference for disease prediction, it is worthy of applica-tion and promotion in clinical.